Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Transplanting neural stem cells (NSC) to the damaged brain has been regarded as a potential treatment for neurodegenerative diseases such as Alzheimer's disease (AD), a condition characterized by memory loss. We hypothesized that transplantation of NSC into the hippocampal regions of APP + PS1 transgenic (Tg) mice, a well‐established model of AD, would enhance the expression of synaptic proteins, which may be helpful for improving cognitive function. Our results showed that NSC transplantation significantly improved spatial learning and memory function in Tg mice. The results obtained by real‐time RT‐PCR, immunofluorescence, and Western blot analyses demonstrated that the expression of synaptophysin (SYN) and that of growth‐associated protein‐43 (GAP‐43) in Tg‐NSC mice, 8 weeks after transplantation, were significantly improved compared with what was observed in Tg‐Veh (control) mice. This finding was confirmed by the increase in the number of synapses in Tg‐NSC mice as observed via electron microscopy. Our results suggest that NSC‐induced changes can recover memory loss in APP + PS1 transgenic mice, possibly by establishing new neural circuits resulting from the engrafted NSC. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“Synaptic loss is the pathological basis of cognitive dysfunction in early AD (Lacor et al., 2007; Arendt, 2009), so we chose to study GAP-43 and SYN as indicators of neural plasticity.”
MethodPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 2×
“SYN was reported to be significantly reduced in relation to the deposition of Ab plaques in the hippocampus and cortex, leading to the loss of synapses and dysfunction of synaptic transmission (Hamos et al., 1989; Terry et al., 1991; Hsia et al., 1999).”
BackgroundNagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · cited 1×
“…AD symptoms, especially improving cognitive decline by enhancing ACh concentration, amyloid clearance, and neuroprotective effects (Birmingham and Frantz, 2002; Musia et al., 2007; Tuszynski, 2009; Nagahara et al., 2009; Carlson et al., 2011; Imbimbo and Giardina, 2011; Blennow et al., 2012).”
BackgroundNeurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715 · cited 1×
“The neurotoxicity of abnormal Ab deposition is commonly believed to lead to neuronal and synaptic loss, causing the progressive cognitive decline commonly observed in AD patients (Selkoe, 2002; Forman et al., 2004; Mattson, 2004; Blennow et al., 2006).”
BackgroundSynaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · cited 1×
“Synaptic loss is the pathological basis of cognitive dysfunction in early AD (Lacor et al., 2007; Arendt, 2009), so we chose to study GAP-43 and SYN as indicators of neural plasticity.”
MethodSynaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432 · cited 1×
“SYN was reported to be significantly reduced in relation to the deposition of Ab plaques in the hippocampus and cortex, leading to the loss of synapses and dysfunction of synaptic transmission (Hamos et al., 1989; Terry et al., 1991; Hsia et al., 1999).”
BackgroundZetterberg, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.90 · Cited by 234 · cited 2×
“…AD symptoms, especially improving cognitive decline by enhancing ACh concentration, amyloid clearance, and neuroprotective effects (Birmingham and Frantz, 2002; Musia et al., 2007; Tuszynski, 2009; Nagahara et al., 2009; Carlson et al., 2011; Imbimbo and Giardina, 2011; Blennow et al., 2012).”
BackgroundMethod
Cited by
Li, B., Liu, J., Gu, G., Han, X., Zhang, Q., & Zhang, W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15001 · Cited by 110
Self-citationMesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200219 · Cited by 73
Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
Alipour, M., Nabavi, S. M., Arab, L., Vosough, M., Pakdaman, H., Ehsani, E., & Shahpasand, K. (2019) · Molecular Biology Reports · doi:10.1007/s11033-018-4499-7 · Cited by 63
Metadata
- Authors
- Zhang, W., Wang, G. M., Wang, P. J., Zhang, Q., & Sha, S. H.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2013-11-21
- Volume
- 92
- Issue
- 2
- Pages
- 185-194
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1716588438
- Cited by
- 53
- References
- 9
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.